Horizon Therapeutics Pub... Stock Price - HZNP

0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Horizon Therapeutics Public Limited Company HZNP NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.54 1.13% 48.12 47.05 48.45 47.55 47.58 20:00:00
Bid Price Ask Price Spread Spread % News
46.00 50.33 4.33 8.6% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
22,036 2,773,441 $ 47.90 $ 132,842,635 2,742,882 22.69 - 52.10
Last Trade Time Type Quantity Stock Price Currency
16:53:03 priorref 1,245 $ 48.12 USD

Horizon Therapeutics Pub... Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 9.18B 190.78M 187.91M $ 1.30B $ 567.33M 2.88 15.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Horizon Therapeutics Pub... News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical HZNP Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week49.4352.1046.7949.402,567,781-1.31-2.65%
1 Month41.6352.1041.3547.472,473,9706.4915.59%
3 Months28.1152.1023.8137.342,460,25820.0171.18%
6 Months32.6252.1023.8136.422,003,05315.5047.52%
1 Year24.9052.1022.6932.321,709,88323.2293.25%
3 Years10.6552.1010.1021.271,970,79837.47351.83%
5 Years31.2452.109.4519.782,845,32116.8854.03%

Horizon Therapeutics Pub... Description

Horizon Therapeutics PLC is a specialty and generic drug manufacturing company. The company is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. The company has two reportable segments: orphan and rheumatology segment and the inflammation segment. It markets medicines in the areas of orphan diseases, rheumatology and inflammation division. The majority of revenue is generated in the United States.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.